How to add online contraception prescribing to a UK clinic in 2026

Contraception is one of the most natural fits for online prescribing in UK telehealth. The patient need is steady, the clinical pathway is well-evidenced, and most consultations can be conducted safely without physical examination provided the right screening is in place. Adding online contraception prescribing to an existing UK clinic in 2026 means building a clinical pathway aligned with the UK Medical Eligibility Criteria (UKMEC), handling under-18 patients with the Fraser-competence framework, and integrating with a compliant dispensing operation. This piece is the launch brief.

Why contraception suits remote care

Contraception telehealth has scaled across the UK since 2020, driven by patient preference for convenience and discretion and by NHS sexual health and GP capacity constraints. The category is well-suited to remote care: most consultations can be conducted safely by structured questionnaire and remote consultation, the treatment list is well-defined, and the ongoing supply model is established.

The exceptions — emergency contraception requiring fast turnaround, LARC (long-acting reversible contraception) insertion requiring in-person procedure, complex hormonal cases — define the boundaries of remote care without invalidating its core fitness for purpose.

Clinical scope — combined pill, progestogen-only, emergency contraception, LARC coordination

The clinical scope for a UK contraception telehealth service typically covers: combined oral contraceptive (COC), progestogen-only pill (POP), emergency contraception (ulipristal acetate, levonorgestrel), patches, vaginal rings, and signposting/coordination for LARC (IUD, IUS, implants, injectables) where the procedure requires in-person provision.

Brands and clinics adding contraception should typically launch with COC and POP plus emergency contraception — the highest-volume and most patient-demanded categories — and add patches and rings later as the operation matures. LARC coordination (booking in-person procedures with appropriate providers) is a service add-on that strengthens the offering.

Eligibility, screening, and the UKMEC framework

UK Medical Eligibility Criteria (UKMEC) frame contraception prescribing decisions based on individual risk profile. UKMEC categories run from 1 (no restriction) to 4 (unacceptable risk). The clinical pathway must screen for the conditions UKMEC flags: cardiovascular risk factors, history of thrombosis, migraine with aura, breast cancer history, smoking and age combinations for COC, certain medications, and pregnancy status.

Combined hormonal contraceptive prescribing requires baseline blood pressure measurement under standard UK practice. The clinical pathway should request this — typically by directing patients to home BP measurement via approved device or recent pharmacy or GP reading — and refuse to prescribe COC without it. A pathway that prescribes COC without BP is operating outside standard UK practice.

Patient pathway — initiation, repeat supply, switching

Standard contraception patient pathways: initial consultation with full medical history, UKMEC screening, and BP for COC candidates. Initiation with patient choice of method, supplied with clear patient information. Ongoing repeat supply with annual review including BP recheck for COC continuers and any change in clinical status. Switching reviews where patient experience or tolerability prompts a change of method.

A pathway that auto-refills indefinitely without review is not defensible. Annual review is standard UK practice for ongoing contraception and should be built into the supply cadence — not bolted on as a marketing afterthought.

Safeguarding considerations including under-18 patients

Patients under 16 require Fraser-competence assessment before contraceptive prescribing — assessment that the patient understands the advice, cannot be persuaded to inform parents, is likely to begin or continue sexual activity, and that providing contraception is in the patient's best interests. The assessment must be documented in the patient record.

Safeguarding considerations extend beyond age. Coercive control, vulnerable adults, and concerns about household relationships should trigger structured safeguarding pathway including escalation routes and liaison with statutory services where appropriate. Contraception services that handle these cases well are part of the safeguarding net; services that miss them are part of the risk.

Regulatory posture and what changes when you add contraception

Adding contraception to an existing UK clinic does not change which regulators oversee you — GPhC for the dispensing pharmacy, MHRA for medicines, CQC for the clinical service in England, ICO for data, ASA for advertising. What does change is the breadth of clinical scope, the safeguarding obligations (particularly for under-18s), and the DPIA coverage of sensitive contraception-related data.

Update the DPIA before launching the new service line. Update the clinical governance framework to reflect the new pathways. Update the SOPs to cover the specific contraception protocols. Update advertising compliance review to handle the new product mix. None of this is difficult; all of it is necessary.

How PExpo supports clinics adding contraception

PExpo's clinic model provides the dispensing layer for contraception services with £0 platform fees and a transparent admin client care fee per request. The dispensing operation handles COC, POP, emergency contraception, patches and rings. The clinic retains the patient relationship and the clinical service registration.

For a UK clinic adding online contraception prescribing in 2026, the dispensing partnership pattern is almost always the right call rather than building in-house dispensing — which would require GPhC premises registration and superintendent pharmacist recruitment. See our clinic model page for what's included, our pricing page for the commercial structure, and our integrations page for the workflow tooling.

An annual review is standard UK practice for ongoing contraception. Build it into the supply cadence — not bolted on as a marketing afterthought.

Adding online contraception prescribing to a UK clinic in 2026 is a low-friction, high-value expansion when the clinical pathway is built properly — UKMEC alignment, BP for COC, annual review built into supply, Fraser competence for under-16s. The clinics that do this well capture durable patient relationships; the ones that prescribe carelessly create regulatory exposure that does not show up in revenue dashboards. See our clinic model page for the dispensing setup, our pricing page for the commercial structure, and our brand model page if you are building a dedicated contraception brand rather than adding to an existing clinic.

Frequently asked questions